-transparent.png){kind=logo}
The fibrinolytic system of the blood was studied in 49 indigenous residents at an altitude of 3600 m above sea level having signs of altitude pulmonary hypertension, and in 48 persons without such signs. The control group comprised 70 residents of Dushanbe (810 m above sea level). Persons with altitude pulmonary hypertension were found to have an increased fibrinolytic activity, a reduced content of antiplasmins and inhibitors of plasminogen activation. These changes are combined with a reduction of the fibrinogen content and a decrease in the activity of the fibrin-stabilizing factor. No principal difference was found in the fibrinolytic system of comparable groups having signs of altitude pulmonary hypertension, and without such signs.
M Kh Bobokhodzhaev, and
F A Chernaia
June 1966,
American heart journal,
M Kh Bobokhodzhaev, and
F A Chernaia
July 1965,
Lancet (London, England),
M Kh Bobokhodzhaev, and
F A Chernaia
January 2018,
Cardiovascular & hematological disorders drug targets,
M Kh Bobokhodzhaev, and
F A Chernaia
March 2009,
European respiratory review : an official journal of the European Respiratory Society,
M Kh Bobokhodzhaev, and
F A Chernaia
June 2013,
High altitude medicine & biology,
M Kh Bobokhodzhaev, and
F A Chernaia
June 2019,
The European respiratory journal,
M Kh Bobokhodzhaev, and
F A Chernaia
November 1963,
The Journal of pediatrics,
M Kh Bobokhodzhaev, and
F A Chernaia
December 1966,
The American journal of cardiology,
M Kh Bobokhodzhaev, and
F A Chernaia
May 2020,
Journal of applied physiology (Bethesda, Md. : 1985),
M Kh Bobokhodzhaev, and
F A Chernaia
July 1996,
Chest,
